About David Bourne
David Bourne is the President of Bourne Strategic.
With a strong scientific background, David employs a blend of skills in strategy and business development to accelerate growth. He has worked for startup through large-cap companies.
David started his career in research and development, then moved to sales and marketing, business unit leadership, global business development, strategic planning and corporate development. In addition, he has led each of these functions. This broad experience has enabled David to see a holistic picture of a company, identify opportunities and enhance its growth.
He has been involved in multiple in vitro diagnostics and life science tools company acquisitions, on both sides of the transaction, and led several M&A deals.
David joined the small-cap company Tm Bioscience in 2006, which was the first molecular diagnostic company acquired by Luminex Corporation, whose annual revenue approached $50M at that time. For the next 15 years, culminating as the Vice President of Business Development and Strategic Planning, David substantially contributed to the company’s growth, which reached almost $500M in annual revenue when it was acquired by DiaSorin in 2021.
Market Segment Experience
In Vitro Diagnostics and Life Science Tools
18
years
Pharma
5
years
Deal Negotiation Experience
Deals Signed
>100
Combined Deal Value
>$600M
Functional Area Leadership Experience
Global Business Development and Licensing
Alliance Management
Business Leader (GM)
M&A
Corporate Development
Strategic Planning
Sales and Marketing
Research and Development
Former Employers
